RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @nciccr_gmb: .@FatimaKarzai has a study of PDL1 inhbition with PARP inhibition in mCRPC (#ProstateCancer) @NCIResearchCtr https://t.co/M…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @MichaelodwyerMD: Interesting paper showing that PARP inhibition sensitizes cancer cells to NK mediated killing in part via upregulation…
One more cool potential combo with NK cell based immunotherapy!
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
Interesting paper showing that PARP inhibition sensitizes cancer cells to NK mediated killing in part via upregulation of DR5 and enhanced death receptor mediated apoptosis
RT @rafaelsirera: An interesting study supporting combination therapy using ADCC-mediating mAbs and olaparib regardless of BRCA status in a…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
An interesting study supporting combination therapy using ADCC-mediating mAbs and olaparib regardless of BRCA status in a variety of tumor types, exploiting NK cells activity. https://t.co/hkiy9FJZlL
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
.@FatimaKarzai has a study of PDL1 inhbition with PARP inhibition in mCRPC (#ProstateCancer) @NCIResearchCtr
RT @gulleyj1: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agen…
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/fFNFKVqq38
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
#JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/GmZe6KTyE4 https://t.co/CWh4dNjYKF
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/DM1CkX7DaR
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
#JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/GmZe6KTyE4 https://t.co/wlVWmEKDLV
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
RT @sitcancer: #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADC…
#JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/GmZe6KTyE4 https://t.co/RjT4Dkwlg6
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/bHjaMGaJnX
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition. by Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh …
RT @sitcancer: New #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity…
RT @sitcancer: New #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity…
New #JITC Research: Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition https://t.co/GmZe6KTyE4 https://t.co/MhwjTpx1Yc